Aspiriant LLC’s Vanguard Growth ETF VUG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.39M | Sell |
74,004
-3,498
| -5% | -$272K | 0.15% | 67 |
|
|
2025
Q4 | $6.3M | Buy |
77,502
+864
| +1% | +$70.1K | 0.18% | 62 |
|
|
2025
Q3 | $6.13M | Buy |
76,638
+4,932
| +7% | +$377K | 0.19% | 55 |
|
|
2025
Q2 | $5.24M | Hold |
71,706
| – | – | 0.17% | 61 |
|
|
2025
Q1 | $4.43M | Sell |
71,706
-6,918
| -9% | -$466K | 0.15% | 59 |
|
|
2024
Q4 | $5.38M | Sell |
78,624
-7,380
| -9% | -$496K | 0.19% | 56 |
|
|
2024
Q3 | $5.5M | Buy |
86,004
+1,752
| +2% | +$109K | 0.21% | 52 |
|
|
2024
Q2 | $5.25M | Buy |
84,252
+19,128
| +29% | +$1.12M | 0.21% | 54 |
|
|
2024
Q1 | $3.74M | Sell |
65,124
-564
| -0.9% | -$31K | 0.15% | 64 |
|
|
2023
Q4 | $3.4M | Sell |
65,688
-270
| -0.4% | -$13K | 0.15% | 66 |
|
|
2023
Q3 | $2.99M | Buy |
65,958
+6,600
| +11% | +$312K | 0.15% | 69 |
|
|
2023
Q2 | $2.8M | Sell |
59,358
-9,774
| -14% | -$424K | 0.14% | 73 |
|
|
2023
Q1 | $2.87M | Buy |
69,132
+8,004
| +13% | +$311K | 0.15% | 74 |
|
|
2022
Q4 | $2.17M | Sell |
61,128
-8,808
| -13% | -$324K | 0.11% | 84 |
|
|
2022
Q3 | $2.49M | Sell |
69,936
-246
| -0.4% | -$9.89K | 0.12% | 72 |
|
|
2022
Q2 | $2.61M | Buy |
70,182
+192
| +0.3% | +$7.89K | 0.13% | 73 |
|
|
2022
Q1 | $3.35M | Buy |
69,990
+9,510
| +16% | +$450K | 0.18% | 63 |
|
|
2021
Q4 | $3.23M | Sell |
60,480
-2,796
| -4% | -$146K | 0.17% | 66 |
|
|
2021
Q3 | $3.06M | Buy |
63,276
+2,016
| +3% | +$100K | 0.18% | 58 |
|
|
2021
Q2 | $2.93M | Buy |
61,260
+13,692
| +29% | +$622K | 0.17% | 64 |
|
|
2021
Q1 | $2.04M | Buy |
47,568
+31,836
| +202% | +$1.36M | 0.13% | 66 |
|
|
2020
Q4 | $664K | Sell |
15,732
-828
| -5% | -$33K | 0.05% | 133 |
|
|
2020
Q3 | $628K | Sell |
16,560
-222
| -1% | -$8.2K | 0.05% | 137 |
|
|
2020
Q2 | $565K | Buy |
16,782
+726
| +5% | +$22.3K | 0.05% | 123 |
|
|
2020
Q1 | $419K | Sell |
16,056
-198
| -1% | -$5.93K | 0.04% | 133 |
|
|
2019
Q4 | $493K | Hold |
16,254
| – | – | 0.05% | 138 |
|
|
2019
Q3 | $451K | Sell |
16,254
-78
| -0.5% | -$2.16K | 0.04% | 154 |
|
|
2019
Q2 | $445K | Sell |
16,332
-15,900
| -49% | -$425K | 0.04% | 158 |
|
|
2019
Q1 | $840K | Buy |
32,232
+3,972
| +14% | +$98K | 0.07% | 121 |
|
|
2018
Q4 | $633K | Sell |
28,260
-1,500
| -5% | -$36.3K | 0.05% | 131 |
|
|
2018
Q3 | $798K | Hold |
29,760
| – | – | 0.07% | 121 |
|
|
2018
Q2 | $743K | Sell |
29,760
-29,130
| -49% | -$714K | 0.06% | 130 |
|
|
2018
Q1 | $1.39M | Buy |
+58,890
| New | +$1.44M | 0.12% | 86 |
|
|
2016
Q3 | – | Sell |
-21,204
| Closed | -$379K | – | 203 |
|
|
2016
Q2 | $379K | Buy |
21,204
+7,278
| +52% | +$130K | 0.04% | 151 |
|
|
2016
Q1 | $247K | Hold |
13,926
| – | – | 0.02% | 155 |
|
|
2015
Q4 | $247K | Sell |
13,926
-45,252
| -76% | -$811K | 0.03% | 72 |
|
|
2015
Q3 | $1.02M | Buy |
59,178
+31,326
| +112% | +$555K | 0.08% | 54 |
|
|
2015
Q2 | $497K | Buy |
+27,852
| New | +$506K | 0.05% | 75 |
|
|
2014
Q1 | – | Sell |
-15,096
| Closed | -$234K | – | 86 |
|
|
2013
Q4 | $234K | Sell |
15,096
-12,456
| -45% | -$184K | 0.04% | 67 |
|
|
2013
Q3 | $389K | Sell |
27,552
-14,292
| -34% | -$197K | 0.07% | 38 |
|
|
2013
Q2 | $545K | Buy |
+41,844
| New | +$552K | 0.09% | 46 |
|
Other funds holding VUG
EWA
Aspiriant LLC's VUG Position: Q1 2026 in Review
Aspiriant LLC reduced its Vanguard Growth ETF (VUG) stake by 4.5% in Q1 2026, selling an estimated $272K and leaving 74,004 shares worth $5.39M. The position accounts for 0.15% of the portfolio, ranked #67.
Aspiriant LLC first reported a position in VUG in Q2 2013 and has held it in 41 quarters since. The position peaked at $6.3M in Q4 2025. 2,720 funds tracked by Wall St. Rank hold VUG as of Q1 2026.
- Aspiriant LLC held 74,004 shares of Vanguard Growth ETF worth $5.39M as of Q1 2026.
- Aspiriant LLC sold 3,498 Vanguard Growth ETF shares in Q1 2026, an estimated $272K.
- Vanguard Growth ETF made up 0.15% of Aspiriant LLC's portfolio in Q1 2026, its #67 holding.
- Aspiriant LLC first reported a position in Vanguard Growth ETF in Q2 2013 and has held it in 41 quarters since.
- Aspiriant LLC's Vanguard Growth ETF position peaked at $6.3M in Q4 2025.
- 2,720 funds tracked by Wall St. Rank held Vanguard Growth ETF as of Q1 2026.
Based on Aspiriant LLC's 13F filing for Q1 2026, filed 12 May 2026.